Phosphorylation-dependent YAP translocation is a well-known intracellular mechanism of the Hippo pathway; however, the molecular effectors governing YAP cytoplasmic translocation remains undefined. Recent findings indicate that oncogenic YAP paradoxically suppresses Wnt activity. Here, we show that Wnt scaffolding protein Dishevelled (DVL) is responsible for cytosolic translocation of phosphorylated YAP. Mutational inactivation of the nuclear export signal embedded in DVL leads to nuclear YAP retention, with an increase in TEAD transcriptional activity. DVL is also required for YAP subcellular localization induced by E-cadherin, α-catenin, or AMPK activation. Importantly, the nuclear-cytoplasmic trafficking is dependent on the p53-Lats2 or LKB1-AMPK tumor suppressor axes, which determine YAP phosphorylation status. In vivo and clinical data support that the loss of p53 or LKB1 relieves DVL-linked reciprocal inhibition between the Wnt and nuclear YAP activity. Our observations provide mechanistic insights into controlled proliferation coupled with epithelial polarity during development and human cancer.

Cancer Cell and Molecular Biology Branch National Cancer Center Ilsan 10408 Korea

Department of Oral and Maxillofacial Surgery Yonsei University College of Dentistry Seoul 03722 Korea

Department of Oral Pathology Yonsei University College of Dentistry Seoul 03722 Korea

Institute of Experimental Biology Faculty of Science Masaryk University Brno 62500 Czech Republic

Oral Cancer Research Institute Yonsei University College of Dentistry Seoul 03722 Korea

Zobrazit více v PubMed

Dong J, et al. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell. 2007;130:1120–1133. doi: 10.1016/j.cell.2007.07.019. PubMed DOI PMC

Moroishi T, Hansen CG, Guan KL. The emerging roles of YAP and TAZ in cancer. Nat. Rev. Cancer. 2015;15:73–79. doi: 10.1038/nrc3876. PubMed DOI PMC

Zhao B, Tumaneng K, Guan KL. The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal. Nat. Cell Biol. 2011;13:877–883. doi: 10.1038/ncb2303. PubMed DOI PMC

Yu FX, Zhao B, Guan KL. Hippo pathway in organ size control, tissue homeostasis, and cancer. Cell. 2015;163:811–828. doi: 10.1016/j.cell.2015.10.044. PubMed DOI PMC

Zhao B, et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev. 2007;21:2747–2761. doi: 10.1101/gad.1602907. PubMed DOI PMC

Zhao B, Li L, Tumaneng K, Wang CY, Guan KL. A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP) Genes Dev. 2010;24:72–85. doi: 10.1101/gad.1843810. PubMed DOI PMC

Wang W, et al. AMPK modulates Hippo pathway activity to regulate energy homeostasis. Nat. Cell Biol. 2015;17:490–499. doi: 10.1038/ncb3113. PubMed DOI PMC

Mo JS, et al. Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway. Nat. Cell Biol. 2015;17:500–510. doi: 10.1038/ncb3111. PubMed DOI PMC

Clevers H, Nusse R. Wnt/beta-catenin signaling and disease. Cell. 2012;149:1192–1205. doi: 10.1016/j.cell.2012.05.012. PubMed DOI

Gottardi CJ, Gumbiner BM. Distinct molecular forms of beta-catenin are targeted to adhesive or transcriptional complexes. J. Cell Biol. 2004;167:339–349. doi: 10.1083/jcb.200402153. PubMed DOI PMC

Konsavage WM, Jr., Yochum GS. Intersection of Hippo/YAP and Wnt/beta-catenin signaling pathways. Acta Biochim. Biophys. Sin. (Shanghai). 2013;45:71–79. doi: 10.1093/abbs/gms084. PubMed DOI

Varelas X, et al. The Hippo pathway regulates Wnt/beta-catenin signaling. Dev. Cell. 2010;18:579–591. doi: 10.1016/j.devcel.2010.03.007. PubMed DOI

Barry ER, et al. Restriction of intestinal stem cell expansion and the regenerative response by YAP. Nature. 2013;493:106–110. doi: 10.1038/nature11693. PubMed DOI PMC

Imajo M, Miyatake K, Iimura A, Miyamoto A, Nishida E. A molecular mechanism that links Hippo signalling to the inhibition of Wnt/beta-catenin signalling. EMBO J. 2012;31:1109–1122. doi: 10.1038/emboj.2011.487. PubMed DOI PMC

Li VS, Clevers H. Intestinal regeneration: YAP-tumor suppressor and oncoprotein? Curr. Biol. 2013;23:R110–112. doi: 10.1016/j.cub.2012.12.021. PubMed DOI

Azzolin L, et al. YAP/TAZ incorporation in the beta-catenin destruction complex orchestrates the Wnt response. Cell. 2014;158:157–170. doi: 10.1016/j.cell.2014.06.013. PubMed DOI

Klingensmith J, et al. Conservation of dishevelled structure and function between flies and mice: isolation and characterization of Dvl2. Mech. Dev. 1996;58:15–26. doi: 10.1016/S0925-4773(96)00549-7. PubMed DOI

Tissir F, Goffinet AM. Expression of planar cell polarity genes during development of the mouse CNS. Eur. J. Neurosci. 2006;23:597–607. doi: 10.1111/j.1460-9568.2006.04596.x. PubMed DOI

Gray RS, et al. Diversification of the expression patterns and developmental functions of the dishevelled gene family during chordate evolution. Dev. Dyn. 2009;238:2044–2057. doi: 10.1002/dvdy.22028. PubMed DOI PMC

Gan XQ, et al. Nuclear Dvl, c-Jun, beta-catenin, and TCF form a complex leading to stabilization of beta-catenin-TCF interaction. J. Cell Biol. 2008;180:1087–1100. doi: 10.1083/jcb.200710050. PubMed DOI PMC

Gao C, Chen YG. Dishevelled: The hub of Wnt signaling. Cell Signal. 2010;22:717–727. doi: 10.1016/j.cellsig.2009.11.021. PubMed DOI

Paclikova P, Bernatik O, Radaszkiewicz TW, Bryja V. N-terminal part of Dishevelled DEP domain is required for Wnt/beta-catenin signaling in mammalian cells. Mol. Cell. Biol. 2017;37:e00145–00117. doi: 10.1128/MCB.00145-17. PubMed DOI PMC

Wallingford JB, Habas R. The developmental biology of Dishevelled: an enigmatic protein governing cell fate and cell polarity. Development. 2005;132:4421–4436. doi: 10.1242/dev.02068. PubMed DOI

Oka T, et al. Functional complexes between YAP2 and ZO-2 are PDZ domain-dependent, and regulate YAP2 nuclear localization and signalling. Biochem. J. 2010;432:461–472. doi: 10.1042/BJ20100870. PubMed DOI

Oudhoff MJ, et al. Control of the hippo pathway by Set7-dependent methylation of Yap. Dev. Cell. 2013;26:188–194. doi: 10.1016/j.devcel.2013.05.025. PubMed DOI

Zhao B, et al. Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein. Genes Dev. 2011;25:51–63. doi: 10.1101/gad.2000111. PubMed DOI PMC

Schuchardt BJ, et al. Molecular basis of the binding of YAP transcriptional regulator to the ErbB4 receptor tyrosine kinase. Biochimie. 2014;101:192–202. doi: 10.1016/j.biochi.2014.01.011. PubMed DOI PMC

Chen HI, Sudol M. The WW domain of Yes-associated protein binds a proline-rich ligand that differs from the consensus established for Src homology 3-binding modules. Proc. Natl Acad. Sci. U.S.A. 1995;92:7819–7823. doi: 10.1073/pnas.92.17.7819. PubMed DOI PMC

Rosin-Arbesfeld R, Townsley F, Bienz M. The APC tumour suppressor has a nuclear export function. Nature. 2000;406:1009–1012. doi: 10.1038/35023016. PubMed DOI

Henderson BR. Nuclear-cytoplasmic shuttling of APC regulates beta-catenin subcellular localization and turnover. Nat. Cell Biol. 2000;2:653–660. doi: 10.1038/35023605. PubMed DOI

Yook JI, et al. A Wnt-Axin2-GSK3beta cascade regulates Snail1 activity in breast cancer cells. Nat. Cell Biol. 2006;8:1398–1406. doi: 10.1038/ncb1508. PubMed DOI

Itoh K, Brott BK, Bae GU, Ratcliffe MJ, Sokol SY. Nuclear localization is required for Dishevelled function in Wnt/beta-catenin signaling. J. Biol. 2005;4:3. doi: 10.1186/jbiol20. PubMed DOI PMC

Morin PJ, et al. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science. 1997;275:1787–1790. doi: 10.1126/science.275.5307.1787. PubMed DOI

Niehrs C. The complex world of WNT receptor signalling. Nat. Rev. Mol. Cell Biol. 2012;13:767–779. doi: 10.1038/nrm3470. PubMed DOI

Park HW, et al. Alternative Wnt signaling activates YAP/TAZ. Cell. 2015;162:780–794. doi: 10.1016/j.cell.2015.07.013. PubMed DOI PMC

Schlegelmilch K, et al. Yap1 acts downstream of alpha-catenin to control epidermal proliferation. Cell. 2011;144:782–795. doi: 10.1016/j.cell.2011.02.031. PubMed DOI PMC

Kim NG, Koh E, Chen X, Gumbiner BM. E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components. Proc. Natl Acad. Sci. U.S.A. 2011;108:11930–11935. doi: 10.1073/pnas.1103345108. PubMed DOI PMC

Silvis MR, et al. Alpha-catenin is a tumor suppressor that controls cell accumulation by regulating the localization and activity of the transcriptional coactivator Yap1. Sci. Signal. 2011;4:ra33. doi: 10.1126/scisignal.2001823. PubMed DOI PMC

Noordermeer J, Klingensmith J, Perrimon N, Nusse R. Dishevelled and armadillo act in the wingless signalling pathway in Drosophila. Nature. 1994;367:80–83. doi: 10.1038/367080a0. PubMed DOI

Aylon Y, et al. A positive feedback loop between the p53 and Lats2 tumor suppressors prevents tetraploidization. Genes Dev. 2006;20:2687–2700. doi: 10.1101/gad.1447006. PubMed DOI PMC

Kim NH, et al. p53 and microRNA-34 are suppressors of canonical Wnt signaling. Sci. Signal. 2011;4:ra71. PubMed PMC

Riley T, Sontag E, Chen P, Levine A. Transcriptional control of human p53-regulated genes. Nat. Rev. Mol. Cell Biol. 2008;9:402–412. doi: 10.1038/nrm2395. PubMed DOI

Wei CL, et al. A global map of p53 transcription-factor binding sites in the human genome. Cell. 2006;124:207–219. doi: 10.1016/j.cell.2005.10.043. PubMed DOI

Kim NH, et al. A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial-mesenchymal transition. J. Cell Biol. 2011;195:417–433. doi: 10.1083/jcb.201103097. PubMed DOI PMC

Shaw RJ, et al. The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc. Natl Acad. Sci. U.S.A. 2004;101:3329–3335. doi: 10.1073/pnas.0308061100. PubMed DOI PMC

Sanchez-Cespedes M, et al. Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung. Cancer Res. 2002;62:3659–3662. PubMed

Ding L, et al. Somatic mutations affect key pathways in lung adenocarcinoma. Nature. 2008;455:1069–1075. doi: 10.1038/nature07423. PubMed DOI PMC

Jeon SM, Chandel NS, Hay N. AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress. Nature. 2012;485:661–665. doi: 10.1038/nature11066. PubMed DOI PMC

Ji H, et al. LKB1 modulates lung cancer differentiation and metastasis. Nature. 2007;448:807–810. doi: 10.1038/nature06030. PubMed DOI

Cai J, Maitra A, Anders RA, Taketo MM, Pan D. beta-Catenin destruction complex-independent regulation of Hippo-YAP signaling by APC in intestinal tumorigenesis. Genes Dev. 2015;29:1493–1506. doi: 10.1101/gad.264515.115. PubMed DOI PMC

Yook JI, Li XY, Ota I, Fearon ER, Weiss SJ. Wnt-dependent regulation of the E-cadherin repressor snail. J. Biol. Chem. 2005;280:11740–11748. doi: 10.1074/jbc.M413878200. PubMed DOI

Zeng X, et al. A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation. Nature. 2005;438:873–877. doi: 10.1038/nature04185. PubMed DOI PMC

Kumagai A, Dunphy WG. Binding of 14-3-3 proteins and nuclear export control the intracellular localization of the mitotic inducer Cdc25. Genes Dev. 1999;13:1067–1072. doi: 10.1101/gad.13.9.1067. PubMed DOI PMC

Brunet A, et al. 14-3-3 transits to the nucleus and participates in dynamic nucleocytoplasmic transport. J. Cell Biol. 2002;156:817–828. doi: 10.1083/jcb.200112059. PubMed DOI PMC

Aguilera C, et al. Efficient nuclear export of p65-IkappaBalpha complexes requires 14-3-3 proteins. J. Cell Sci. 2006;119:3695–3704. doi: 10.1242/jcs.03086. PubMed DOI

Mana-Capelli S, Paramasivam M, Dutta S, McCollum D. Angiomotins link F-actin architecture to Hippo pathway signaling. Mol. Biol. Cell. 2014;25:1676–1685. doi: 10.1091/mbc.e13-11-0701. PubMed DOI PMC

Moleirinho S, et al. Regulation of localization and function of the transcriptional co-activator YAP by angiomotin. eLife. 2017;6:e23966. doi: 10.7554/eLife.23966. PubMed DOI PMC

Adler JJ, et al. Serum deprivation inhibits the transcriptional co-activator YAP and cell growth via phosphorylation of the 130-kDa isoform of Angiomotin by the LATS1/2 protein kinases. Proc. Natl Acad. Sci. U.S.A. 2013;110:17368–17373. doi: 10.1073/pnas.1308236110. PubMed DOI PMC

Veeman MT, Axelrod JD, Moon RT. A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling. Dev. Cell. 2003;5:367–377. doi: 10.1016/S1534-5807(03)00266-1. PubMed DOI

Lawrence PA, Casal J. The mechanisms of planar cell polarity, growth and the Hippo pathway: some known unknowns. Dev. Biol. 2013;377:1–8. doi: 10.1016/j.ydbio.2013.01.030. PubMed DOI PMC

Baas AF, et al. Complete polarization of single intestinal epithelial cells upon activation of LKB1 by STRAD. Cell. 2004;116:457–466. doi: 10.1016/S0092-8674(04)00114-X. PubMed DOI

Martin SG, St Johnston D. A role for Drosophila LKB1 in anterior-posterior axis formation and epithelial polarity. Nature. 2003;421:379–384. doi: 10.1038/nature01296. PubMed DOI

Zheng B, Cantley LC. Regulation of epithelial tight junction assembly and disassembly by AMP-activated protein kinase. Proc. Natl Acad. Sci. U.S.A. 2007;104:819–822. doi: 10.1073/pnas.0610157104. PubMed DOI PMC

Zhang L, Li J, Young LH, Caplan MJ. AMP-activated protein kinase regulates the assembly of epithelial tight junctions. Proc. Natl Acad. Sci. U.S.A. 2006;103:17272–17277. doi: 10.1073/pnas.0608531103. PubMed DOI PMC

Sebbagh M, Santoni MJ, Hall B, Borg JP, Schwartz MA. Regulation of LKB1/STRAD localization and function by E-cadherin. Curr. Biol. 2009;19:37–42. doi: 10.1016/j.cub.2008.11.033. PubMed DOI PMC

Bays JL, Campbell HK, Heidema C, Sebbagh M, DeMali KA. Linking E-cadherin mechanotransduction to cell metabolism through force-mediated activation of AMPK. Nat. Cell Biol. 2017;19:724–731. doi: 10.1038/ncb3537. PubMed DOI PMC

Aylon Y, et al. Silencing of the Lats2 tumor suppressor overrides a p53-dependent oncogenic stress checkpoint and enables mutant H-Ras-driven cell transformation. Oncogene. 2009;28:4469–4479. doi: 10.1038/onc.2009.270. PubMed DOI PMC

Kim NH, et al. Snail reprograms glucose metabolism by repressing phosphofructokinase PFKP allowing cancer cell survival under metabolic stress. Nat. Commun. 2017;8:14374. doi: 10.1038/ncomms14374. PubMed DOI PMC

Ahn SY, et al. Niclosamide is a potential therapeutic for familial adenomatosis polyposis by disrupting Axin-GSK3 interaction. Oncotarget. 2017;8:31842–31855. PubMed PMC